Platinum Equity to acquire Energy Distribution Partners after 45 acquisitions and threefold EBITDA growth
Senores Pharmaceuticals (SENORES) targets 3.2bn annual manufacturing units, yet 50% to 70% utilisation raises a bigger question
Aspen Neuroscience (ASPE) prices $140.6m IPO at $15 as Parkinson’s therapy enters pivotal development phase
Read More Pharma Industry News Is Immuron (ASX: IMC) quietly staging a turnaround? PROIBS launch sparks 20% rally Immuron (ASX: IMC) shares jumped 20 percent following its IBS product launch. Can the PROIBS rollout turn this microcap into a digestive health contender? byVenkateshOctober 26, 2025